Patent ID: 6855728

Claim:
A method for modulating HGF/SF activity in a mammal comprising administering to said mammal an effective HGF/SF activity modulating amount of a compound with the general formula I: wherein R3 and R5 are independently or together methyl, t-butyl or chloro groups; R1 is CO-Aryl, SO 2 -Aryl, CO-heteroaryl, or CO-alkyl, wherein said Aryl is phenyl, naphthyl or diphenyl, said Aryl substituted with one or more halogen, C1 to C4 alkyl, or C1 to C4 alkyloxy groups, or said heteroaryl is a 3-aryl-substituted isoxazole or a 3-aryl substituted thienyl group, or said alkyl group is a t-butyl; and R4 is CH2-Aryl, halogen, arylcarbonylvinyl or S-heteroaryl.